Recombinant multi-species PARP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PARP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes poly(ADP-ribosyl)transferase-like 2 protein, which contains a catalytic domain and is capable of catalyzing a poly(ADP-ribosyl)ation reaction. This protein has a catalytic domain which is homologous to that of poly (ADP-ribosyl) transferase, but lacks an N-terminal DNA binding domain which activates the C-terminal catalytic domain of poly (ADP-ribosyl) transferase. The basic residues within the N-terminal region of this protein may bear potential DNA-binding properties, and may be involved in the nuclear and/or nucleolar targeting of the protein. Two alternatively spliced transcript variants encoding distinct isoforms have been found. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ADP-ribosyltransferase diphtheria toxin-like 2 (ARTD2),ADPRT-2,ADPRT2,ADPRTL2,ADPRTL3,ARTD2,Adprt2,Adprtl2,Aspartl2,DNA ADP-ribosyltransferase PARP2,NAD(+) ADP-ribosyltransferase 2 (ADPRT-2),PARP-2,PARP2,Parp2,Poly [ADP-ribose] polymerase 2,Poly[ADP-ribose] synthase 2 (pADPRT-2),Protein poly-ADP-ribosyltransferase PARP2,hPARP-2,mPARP-2,pADPRT-2

Target products collectionGo to PARP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T40812-Ag-1/ GM-Tg-hg-T40812-Ag-2 Human PARP2 protein Human
GM-Tg-rg-T40812-Ag-1/ GM-Tg-rg-T40812-Ag-2 Rat PARP2 protein Rat
GM-Tg-mg-T40812-Ag-1/ GM-Tg-mg-T40812-Ag-2 Mouse PARP2 protein Mouse
GM-Tg-cynog-T40812-Ag-1/ GM-Tg-cynog-T40812-Ag-2 Cynomolgus/Rhesus macaque PARP2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T40812-Ag-1/ GM-Tg-felg-T40812-Ag-2 Feline PARP2 protein Feline
GM-Tg-cang-T40812-Ag-1/ GM-Tg-cang-T40812-Ag-2 Canine PARP2 protein Canine
GM-Tg-bovg-T40812-Ag-1/ GM-Tg-bovg-T40812-Ag-2 Bovine PARP2 protein Bovine
GM-Tg-equg-T40812-Ag-1/ GM-Tg-equg-T40812-Ag-2 Equine PARP2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T40812-Ag-1/ GM-Tg-hg-T40812-Ag-2; GM-Tg-rg-T40812-Ag-1/ GM-Tg-rg-T40812-Ag-2;
GM-Tg-mg-T40812-Ag-1/ GM-Tg-mg-T40812-Ag-2; GM-Tg-cynog-T40812-Ag-1/ GM-Tg-cynog-T40812-Ag-2;
GM-Tg-felg-T40812-Ag-1/ GM-Tg-felg-T40812-Ag-2; GM-Tg-cang-T40812-Ag-1/ GM-Tg-cang-T40812-Ag-2;
GM-Tg-bovg-T40812-Ag-1/ GM-Tg-bovg-T40812-Ag-2; GM-Tg-equg-T40812-Ag-1/ GM-Tg-equg-T40812-Ag-2
Products Name PARP2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PARP2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PARP2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.